We’ve been taught that national parks exist to preserve beauty, biodiversity, and public access to nature. But in reality, they are also repositories of biological intelligence—housing compounds that fuel billion-dollar drug pipelines.

Over 50% of modern medicines originate from nature. Many are discovered in publicly protected lands, researched using public grants, and then locked behind private patents.

This raises critical questions: Are we protecting nature—or monetizing it? Who benefits when public ecosystems become profit engines?

The U.S. is not part of the Nagoya Protocol, which means pharmaceutical companies are not obligated to share profits from natural compounds sourced in U.S. territories.

We must rethink conservation not as scenery preservation—but as natural intelligence governance.

#PublicTrust #Bioprospecting #GoldenEraEthos #IndigenousRights #PharmaWatch #NaturalIntelligence

🍺 Enjoying the insights?
Buy me a beer & keep the intel flowing: 🍻 Buy Me a Beer.